Hemodynamic monitoring system enables continuous monitoring of movement of blood and pressure on the heart, veins and arteries. It also enables measuring blood flow as well as the amount of oxygen present in the blood. It is an efficient collection and analysis of quantitative and qualitative data of cardiopulmonary functions. In the report, we have segmented the market based on technologies and methods: pulse contour, oesophageal Doppler, volume clamp, hemodynamic monitoring sensors and pulmonary artery catheters. The scope of these devices is covered under end use hospitals, clinics, home care settings, ambulatory surgery centers and independent catheterisation laboratories.
In 2014, hemodynamic monitoring systems market was worth US$ 328.7 Mn. North America held the largest share in the global market in 2014 and is expected to retain its dominance over the forecast period.
This report offers updates on advancements in the hemodynamic monitoring systems market. It covers performance in terms of value and volume contribution. It also analyzes key trends, drivers, and restraints that are influencing this market.
The hemodynamic monitoring systems market is anticipated to register healthy CAGR during the forecast period. Factors fuelling market growth include rising prevalence of lifestyle diseases, government, and private sector initiatives to reduce healthcare costs, growing the geriatric patient population, increasing the incidence of respiratory disorders and growing demand for a screening of CCHD.
The global hemodynamic monitoring systems market has been segmented on the basis of device type into the devices based on technologies and methods: pulse contour, oesophageal Doppler, volume clamp, hemodynamic monitoring sensors and pulmonary artery catheters.
The pulmonary artery catheters segment is estimated to dominate the global hemodynamic monitoring systems market with 35.0% share by 2015 end, followed by volume clamp segment. Increasing concerns regarding the use of invasive techniques, particularly pulmonary artery catheter for measuring cardiac output, have paved the way for alternative methods for measuring hemodynamic variables. Cardiac surgeons are increasingly seeking less invasive approaches to aortic or mitral valve surgery. Key players are offering a variety of systems that enable minimal incision valve surgery.
By application, the invasive hemodynamic monitoring segment is projected to lose its dominance throughout the forecast period.
Noninvasive hemodynamic monitoring application segment is expected to gain BPS during the forecast period. However, minimally invasive hemodynamic monitoring segment is forecast to register highest CAGR among all three applications by the end of forecast period.
By end-use, the hemodynamic monitoring systems market is segmented into hospitals, home care settings, clinics, ambulatory surgery centers and independent catheterisation laboratories. Home care settings segment is expected to exhibit above-average growth during the forecast period.
Key market participants included in the report are Edwards Lifesciences Corporation, PULSION Medical Systems SE, ICU Medical, Inc., LiDCO Group Plc and Teleflex Incorporated. Global players focus on research and development initiatives to introduce innovative products in order to attain competitive advantage. Additionally, they are also focused on regional expansion through mergers and acquisitions.
The global hemodynamic monitoring systems market is segmented into:
Global Hemodynamic Monitoring Systems Market, by Device Type
Global Hemodynamic Monitoring Systems Market, by Application
Global Hemodynamic Monitoring Systems Market, by End-Use
Global Hemodynamic Monitoring Systems Market, by Region
MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.Get A Free Custom Research Quote